Focusing on the 24 genes-of-interest, T2D patients were found to express: (i) higher levels of the genes CAPN10, KCNQ1 and TCF7L2 and of the transcripts NM_023085 (CAPN10), NM_000218 (KCNQ1), NM_001198530, NM_001146284, NM_001198527 (all of TCF7L2), NR_073394 (THADA) (Fig. 1B and Supplemental Table 2) and (ii) and lower levels of the genes CDKAL1 and IGF2BP2 and of the transcripts NM_017774 (CDKAL1), NM_001291873, NM_001291872, NM_001291875 (all of IGF2BP2), NM_001271643, NM_001271644, NM_001083953, NM_022065 (all of THADA) (Fig. 1B and Supplemental Table 2), compared to controls. The gene discussed is THADA; the disease is type 2 diabetes mellitus.